1.
Mariani G, Guidi L, Barioglio A. Olanzapine versus typical neuroleptics for schizophrenia: evaluation of social and economic costs. FE [Internet]. 2006 Sep. 15 [cited 2025 Jul. 23];7(2):119-24. Available from: https://provafe.seedstm.com/index.php/FE/article/view/681